Delivery Order SPE2DB24D2012-SPE2DB25FBVKF

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of COSENTYX 300 MG DOSE-2 SYRINGE to the Defense Logistics Agency (DLA). The $1,803.31 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 16, 2024 and was awarded on September 13, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award is for the delivery of COSENTYX 300 mg dose-2 syringes to the Defense Logistics Agency (DLA). The contract, valued at $15,507.06, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, and has an ultimate completion date of March 28, 2023. The contract is not set aside for any specific business type. AmerisourceBergen holds a...
This federal contract award is for the procurement of COSENTYX 150 MG/ML SYRINGEML, a pharmaceutical product, by the Defense Logistics Agency (DLA). The $5,174.31 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 29, 2024 and was not subject to any set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML medical products to the Defense Logistics Agency (DLA), a defense agency. The $1,574.56 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024 with a completion date of November 27, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of COSENTYX 150 MG/ML Syringes to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $5,343.73, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on April 19, 2024. The contract is a Firm Fixed Price Delivery Order with a completion date of April 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of COSENTYX 300 MG DOSE-2 SYRINGEML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $28,850.55 and a completion date of October 30, 2024. The contract is not a set-aside and is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,574.56 Firm Fixed Price Delivery Order is for the supply of COSENTYX 300 MG DOSE-2 SYRINGEML, a specialty pharmaceutical product. The contract has a period of performance through February 26, 2025 and was awarded on February 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of COSENTYX 300 mg dose-2 pre-filled syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,043.92 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals to the Defense Logistics Agency (DLA). The $1,793.26 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024, with a completion date of December 19, 2024. The award is part of a larger, $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,149.12 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024, with a completion date of November 27, 2024. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB25FBVKF
    Delivery Order

This federal contract award is for the delivery of COSENTYX 300 MG DOSE-2 SYRINGE medical products to the Defense Logistics Agency (DLA), a defense agency. The $1,574.56 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a completion date of February 27, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/28/25, 10:48 AM